← Open Payments lookup

RAYMOND SAULS: Open Payments

NPI 1063461408 · LANCASTER, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,347 in 71 payments from 14 companies in 2025. Trend: 2023 $1,531 · 2024 $1,375 · 2025 $1,347

Food & beverage: $1,347
CompanyPaymentsAmount
AstraZeneca Pharmaceuticals LP15$388
PFIZER INC.21$343
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)11$145
Lilly USA, LLC4$94
Boehringer Ingelheim Pharmaceuticals, Inc.3$76
Novo Nordisk Inc4$64
Phathom Pharmaceuticals, Inc.3$57
GlaxoSmithKline, LLC.2$49
Astellas Pharma US Inc2$36
Viatris Specialty LLC2$31

Products named: NURTEC ODT, FARXIGA, CAPLYTA, AIRSUPRA, ELIQUIS, MOUNJARO, VOQUEZNA, TRELEGY ELLIPTA.

Industry payments across MA — which companies pay providers there.